SLC1A1 and schizophrenia: For example, reduced expression of EAAT3 has been observed in the prefrontal cortex of subjects with schizophrenia, and this reduction is thought to contribute to increased glutamate levels and NMDA receptor hyperactivity, which may underlie the cognitive and behavioral impairments associated with this disorder.42